Browse by CSHL Author

[up] Up a level
Group by: Item Type | No Grouping
Jump to: Paper
Number of items at this level: 4.

Paper

Venkataramani, Prabhadevi, Elkayam, Elad, Garg, Ankur, Cheng, Kai Fan, Altiti, Ahmad, He, Mingzhu, Thakur, Khushabu, Michalopoulou, Evdokia, Gonzalez, Camila, Felice, Christy, Van-Aelst, Linda, Pappin, Darryl, Joshua-Tor, Leemor, Al-Abed, Yousef, Tonks, Nicholas K (November 2025) Novel small-molecule inhibitors of the protein kinase DYRK: Potential therapeutic candidates in cancer. bioRxiv. ISSN 2692-8205 (Submitted)

Bencze, Gyula, Venkataramani, Prabhadevi, Elkayam, Elad, Rivera, Keith D, Garg, Ankur, Szabadkai, Istvan, Orfi, Laszlo, Joshua-Tor, Leemor, Pappin, Darryl, Tonks, Nicholas K (October 2025) Identification and Validation of an inhibitor of the protein kinases PIM and DYRK. bioRxiv. ISSN 2692-8205 (Submitted)

Huilgol, D., Venkataramani, P., Nandi, S., Bhattacharjee, S. (October 2019) Transcription Factors That Govern Development and Disease: An Achilles Heel in Cancer. Genes (Basel), 10 (10). ISSN 2073-4425

Ghosh, D., Venkataramani, P., Nandi, S., Bhattacharjee, S. (January 2019) CRISPR-Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics. Cancer Cell Int, 19. p. 12. ISSN 1475-2867 (Print)1475-2867

This list was generated on Tue Dec 9 12:46:12 2025 EST.